Scientific Advisory Board
Dr. Jing-Qiong (Katty) Kang is a physician scientist by training and now an associate professor in the Vanderbilt University Department of Neurology. She is also a faculty member in Vanderbilt Brain Institute, Vanderbilt Kennedy Center and Pharmacology at Vanderbilt University School of Medicine. Dr. Kang received her MD/PhD degree from Tongji Medical University, China, and is a neurologist specialized in epilepsy. Prior to that, she worked at Tongji Hospital. She joined Department of Neurology at in the Wayne State University in August 2001 to study neurodegeneration before she joined Dr. Robert Macdonald’s lab at Vanderbilt University Medical Center in 2003.
Dr. Kang has been invited to present her work in multiple institutes and conferences nationally and internationally. Most recently, she has spoken at American Epilepsy Meeting (AES), Fukuoka University Medical School, Case Western Reserve University, Beijing Tiantan Neurosurgery Summit. She has been the chair for Basic Mechanisms and Neuroscience symposium at the AES meeting from 2015-2018. Dr. Kang is an award recipient of Citizens United for Research in Epilepsy (CURE), Dravet.org (formerly known as IDEA-League), Dravet syndrome foundation (DSF) and National Institute of Neurological Disorders and Stroke (NINDS) and SLC6A1 Connect.
Dr. Kang’s current research centers around using cell models including patient derived induced pluripotent stem cells (iPSCs) and genetically modified mouse models to understand the role of GABAA receptors and GABA transporters in normal development and diseased conditions especially epilepsy and treatment development. Her lab has partnered with industries to develop treatment options and translate the lab discoveries to patient care for these rare brain diseases.